Topical β-blockers for pyogenic granulomas: A promising option for younger patients.

Background: Topical β-blockers, propranolol, and timolol were used for pyogenic granuloma (PG) treatment; however, their efficacies and safety profiles were not compared.

Aims: The aim was to evaluate the safety and efficacy of propranolol 1% and timolol 0.5% creams in the treatment of pyogenic granulomas.

Serum TWEAK: A cutoff between segmental and nonsegmental vitiligo.

Background: TWEAK/Fn14 is expressed in many tissues including the skin, playing an important role in many inflammatory, autoimmune, and neoplastic cutaneous disorders.

Aims: To assess the serum levels of tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in vitiligo patients.

Methods: This case-control study included 100 subjects (50 vitiligo patients and 50 control subjects) recruited from Dermatology Outpatient Clinic, Benha University.

Serum TWEAK in acne vulgaris: An unknown soldier.

Background: TWEAK is an inflammatory cytokine which is involved in the development of many inflammatory disorders.

Aims: This study aimed to evaluate serum levels of TWEAK in patients with acne vulgaris.

Subjects And Methods: This case-controlled study included 100 acne vulgaris patients divided into two groups.